(25 days)
The OWL Radiofrequency System, Model URF-2AP, intended use is for:
- lesioning nerve tissue for functional neurosurgical procedures such as thalamotomies, pallidotomies, tractomies, and myelotomies; or
- radiofrequency heat lesion procedures for the relief of pain.
Not Found
I am sorry, but the provided text does not contain information about acceptance criteria, device performance, or any study details. It is a letter from the FDA regarding a 510(k) premarket notification for a device called the "OWL Radiofrequency System, Model URF-2AP." The letter confirms the device's substantial equivalence to previously marketed devices and lists its indications for use.
Therefore, I cannot fulfill your request to describe the acceptance criteria and the study that proves the device meets them based on the input provided.
§ 882.4400 Radiofrequency lesion generator.
(a)
Identification. A radiofrequency lesion generator is a device used to produce lesions in the nervous system or other tissue by the direct application of radiofrequency currents to selected sites.(b)
Classification. Class II (performance standards).